Search Results 241-250 of 18479 for Crohns disease

1. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease ... and stage of disease, and ...

2. A Study to Evaluate Darvadstrocel in the Treatment of Complex Perianal Fistula in Crohn's Disease Patients - Mayo Clinic

   The purpose of this study is to evaluate the long-term safety of a single dose of darvadstrocel in participants with Crohn's disease (CD) and complex perianal ...

3. Publications - Laura E. Raffals, M.D. - Mayo Clinic

   ... Disease: Hidradenitis Suppurativa and Inflammatory Bowel Disease. ... Vulvar Crohn's Disease: Clinical Features and Outcomes. Am J Gastroenterol ...

4. Gastroenterology, Inflammatory Bowel Disease Fellowship (Minnesota) - Residencies and Fellowships - Mayo Clinic College of Medicine & Science

   Mayo Clinic School of Graduate Medical Education offers the one-year Inflammatory Bowel Disease Fellowship in Rochester, Minnesota.

5. Safety and Efficacy of GS-5745 in Participants With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   This study will primarily evaluate the safety and efficacy of GS-5745 in adults with active Crohn's disease. The study will consist of a Blinded Treatment ...

6. Pseudomembranous colitis - Symptoms & causes - Mayo Clinic

   Certain diseases that affect the colon, such as ulcerative colitis or Crohn's disease, also may put people at risk of pseudomembranous colitis. C. difficile ...

7. Publications - Konstantinos A. Papadakis, M.D. - Mayo Clinic

   Basseri B, Enayati P, Marchevsky A, Papadakis KA. Pulmonary manifestations of inflammatory bowel disease: case presentations and review. J Crohns Colitis. 2010 ...

8. A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER) - Mayo Clinic

   A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER). Print ...

9. Examining HBV vaccine efficacy and durability in individuals with IBD and celiac disease - Mayo Clinic

   Individuals diagnosed with inflammatory bowel disease (IBD) or celiac disease (CD) are presumed to have a suboptimal humoral response to the hepatitis B virus ( ...

10. ROC curve for genetic, clinical, and genetic and clinical risk factors for early surgery in Crohn's disease - Mayo Clinic

    Home · ROC curve for genetic, clinical, and genetic and clinical risk factors for early surgery in Crohn's disease ...